{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T10:24:28Z","timestamp":1783419868932,"version":"3.54.6"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T00:00:00Z","timestamp":1680048000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005088","name":"Beijing Municipal Health Commission","doi-asserted-by":"publisher","award":["2022-1-007"],"award-info":[{"award-number":["2022-1-007"]}],"id":[{"id":"10.13039\/501100005088","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005088","name":"Beijing Municipal Health Commission","doi-asserted-by":"publisher","award":["2022-2-018"],"award-info":[{"award-number":["2022-2-018"]}],"id":[{"id":"10.13039\/501100005088","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009601","name":"Beijing Municipal Administration of Hospitals","doi-asserted-by":"publisher","award":["DFL20191701"],"award-info":[{"award-number":["DFL20191701"]}],"id":[{"id":"10.13039\/501100009601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010876","name":"Shanghai University of Traditional Chinese Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010876","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017962","name":"Jiangsu Commission of Health","doi-asserted-by":"publisher","award":["ZDA 2020014"],"award-info":[{"award-number":["ZDA 2020014"]}],"id":[{"id":"10.13039\/100017962","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Western Pacific"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.lanwpc.2023.100769","type":"journal-article","created":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T01:01:15Z","timestamp":1682298075000},"page":"100769","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Efficacy and safety of ainuovirine versus efavirenz combination therapies with lamivudine\/tenofovir disoproxil fumarate for medication of treatment-na\u00efve HIV-1-positive adults: week 48 results of a randomized controlled phase 3 clinical trial followed by an open-label setting until week 96"],"prefix":"10.1016","volume":"36","author":[{"given":"Bin","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiju","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqiu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linghua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengting","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haolan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixia","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingxia","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxia","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaokai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6386-9879","authenticated-orcid":false,"given":"Fujie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lanwpc.2023.100769_bib1","series-title":"Update of recommendations on first- and second-line antiretroviral regimens","author":"WHO","year":"2019"},{"issue":"9","key":"10.1016\/j.lanwpc.2023.100769_bib2","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1056\/NEJMoa1902824","article-title":"Dolutegravir plus two different prodrugs of tenofovir to treat HIV","volume":"381","author":"Venter","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.lanwpc.2023.100769_bib3","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/QAD.0000000000003069","article-title":"Virologic outcomes among adults with HIV using integrase inhibitor-based antiretroviral therapy","volume":"36","author":"Lu","year":"2022","journal-title":"AIDS"},{"issue":"11","key":"10.1016\/j.lanwpc.2023.100769_bib4","first-page":"1182","article-title":"Chinese guidelines for diagnosis and treatment of HIV\/AIDS (2021)","volume":"27","year":"2021","journal-title":"Chin J AIDS STD"},{"issue":"7","key":"10.1016\/j.lanwpc.2023.100769_bib5","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1517\/17425255.4.7.965","article-title":"Efavirenz--still first-line king?","volume":"4","author":"Best","year":"2008","journal-title":"Expet Opin Drug Metabol Toxicol"},{"issue":"4","key":"10.1016\/j.lanwpc.2023.100769_bib6","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/cid\/ciy540","article-title":"Doravirine\/lamivudine\/tenofovir disoproxil fumarate is non-inferior to efavirenz\/emtricitabine\/tenofovir disoproxil fumarate in treatment-naive adults with human immunodeficiency virus-1 infection: week 48 results of the DRIVE-AHEAD trial","volume":"68","author":"Orkin","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.lanwpc.2023.100769_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191300","article-title":"Long-term efficacy and safety of rilpivirine plus abacavir and lamivudine in HIV-1 infected patients with undetectable viral load","volume":"13","author":"Galizzi","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.lanwpc.2023.100769_bib8","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.2147\/DDDT.S65596","article-title":"Pharmacokinetics and tolerability of the new second-generation nonnucleoside reverse- transcriptase inhibitor KM-023 in healthy subjects","volume":"8","author":"Cha","year":"2014","journal-title":"Drug Des Devel Ther"},{"issue":"5","key":"10.1016\/j.lanwpc.2023.100769_bib9","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2174\/1570162X18666200620211922","article-title":"The new NNRTI ACC007 combined with lamivudine and tenofovir disoproxil fumarate show synergy anti-HIV activity in\u00a0vitro","volume":"18","author":"Huang","year":"2020","journal-title":"Curr HIV Res"},{"key":"10.1016\/j.lanwpc.2023.100769_bib10","author":"DAIDS"},{"issue":"5","key":"10.1016\/j.lanwpc.2023.100769_bib11","doi-asserted-by":"crossref","first-page":"e211","DOI":"10.1016\/S2352-3018(18)30021-3","article-title":"Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial","volume":"5","author":"Molina","year":"2018","journal-title":"Lancet HIV"},{"issue":"1","key":"10.1016\/j.lanwpc.2023.100769_bib12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s40249-020-00700-8","article-title":"Very high baseline HIV viremia impairs efficacy of non-nucleoside reverse transcriptase inhibitor-based ART: a long-term observation in treatment-na\u00efve patients","volume":"9","author":"Chen","year":"2020","journal-title":"Infect Dis Poverty"},{"issue":"19","key":"10.1016\/j.lanwpc.2023.100769_bib13","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1056\/NEJMoa1215541","article-title":"Dolutegravir plus abacavir-lamivudine for the treatment of HIV-1 infection","volume":"369","author":"Walmsley","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.lanwpc.2023.100769_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0222229","article-title":"Dolutegravir based antiretroviral therapy compared to other combined antiretroviral regimens for the treatment of HIV-infected naive patients: a systematic review and meta-analysis","volume":"14","author":"Cruciani","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.lanwpc.2023.100769_bib15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ijid.2017.06.009","article-title":"Efficacy and safety of a once-daily single-tablet regimen of tenofovir, lamivudine, and efavirenz assessed at 144 weeks among antiretroviral-naive and experienced HIV-1-infected Thai adults","volume":"61","author":"Avihingsanon","year":"2017","journal-title":"Int J Infect Dis"},{"issue":"9787","key":"10.1016\/j.lanwpc.2023.100769_bib16","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0140-6736(11)60936-7","article-title":"Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial","volume":"378","author":"Molina","year":"2011","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.lanwpc.2023.100769_bib17","doi-asserted-by":"crossref","first-page":"5922","DOI":"10.1038\/s41467-020-19801-x","article-title":"Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase","volume":"11","author":"Siedner","year":"2020","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.lanwpc.2023.100769_bib18","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12879-021-05794-5","article-title":"Increase in HIV-1-transmitted drug resistance among ART-naive youths at the China-Myanmar border during 2009 \u223c 2017","volume":"21","author":"Ding","year":"2021","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.lanwpc.2023.100769_bib19","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/QAI.0b013e31823df4da","article-title":"Genotypic and phenotypic characterization of HIV-1 isolates obtained from patients on rilpivirine therapy experiencing virologic failure in the phase 3 ECHO and THRIVE studies: 48-week analysis","volume":"59","author":"Rimsky","year":"2012","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"4","key":"10.1016\/j.lanwpc.2023.100769_bib20","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1128\/AAC.02650-15","article-title":"Doravirine suppresses common nonnucleoside reverse transcriptase inhibitor-associated mutants at clinically relevant concentrations","volume":"60","author":"Feng","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.lanwpc.2023.100769_bib21","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/cid\/ciz424","article-title":"Once-daily doravirine in human immunodeficiency virus type 1-infected, antiretroviral-naive adults: an integrated efficacy analysis","volume":"70","author":"Orkin","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"18","key":"10.1016\/j.lanwpc.2023.100769_bib22","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1001\/archinte.163.18.2187","article-title":"CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 Years: the Swiss HIV cohort study","volume":"163","author":"Kaufmann","year":"2003","journal-title":"Arch Intern Med"},{"issue":"10","key":"10.1016\/j.lanwpc.2023.100769_bib23","doi-asserted-by":"crossref","first-page":"e666","DOI":"10.1016\/S2352-3018(20)30241-1","volume":"7","author":"Venter","year":"2020","journal-title":"Lancet HIV"},{"issue":"1","key":"10.1016\/j.lanwpc.2023.100769_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13679-020-00419-5","article-title":"Drugs affecting body weight, body fat distribution, and metabolic function-mechanisms and possible therapeutic or preventive measures: an update","volume":"10","author":"Verhaegen","year":"2021","journal-title":"Curr Obes Rep"},{"issue":"32","key":"10.1016\/j.lanwpc.2023.100769_bib25","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur Heart J"},{"issue":"34","key":"10.1016\/j.lanwpc.2023.100769_bib26","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.lanwpc.2023.100769_bib27","article-title":"Atherosclerotic cardiovascular disease risk assessment: an American Society for Preventive Cardiology clinical practice statement","volume":"10","author":"Wong","year":"2022","journal-title":"Am J Prev Cardiol"},{"issue":"9","key":"10.1016\/j.lanwpc.2023.100769_bib28","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1097\/QAD.0b013e32835f1db0","article-title":"Adverse events associated with nevirapine and efavirenz-based first-line antiretroviral therapy: a systematic review and meta-analysis","volume":"27","author":"Shubber","year":"2013","journal-title":"AIDS"},{"issue":"7","key":"10.1016\/j.lanwpc.2023.100769_bib29","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.3390\/cells10071687","article-title":"NNRTI and liver damage: evidence of their association and the mechanisms involved","volume":"10","author":"Benedicto","year":"2021","journal-title":"Cells"},{"issue":"12","key":"10.1016\/j.lanwpc.2023.100769_bib30","first-page":"1365","article-title":"New progress of AIDS epidemiology in China [article in Chinese]","volume":"25","author":"He","year":"2021","journal-title":"Chin J Dis Control Prev"},{"key":"10.1016\/j.lanwpc.2023.100769_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.652868","article-title":"Long-term changes of HIV\/AIDS incidence rate in China and the U.S. population from 1994 to 2019: a join-point and age-period-cohort analysis","volume":"9","author":"Ma","year":"2021","journal-title":"Front Public Health"}],"container-title":["The Lancet Regional Health - Western Pacific"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666606523000871?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666606523000871?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T02:40:05Z","timestamp":1763001605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666606523000871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":31,"alternative-id":["S2666606523000871"],"URL":"https:\/\/doi.org\/10.1016\/j.lanwpc.2023.100769","relation":{},"ISSN":["2666-6065"],"issn-type":[{"value":"2666-6065","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of ainuovirine versus efavirenz combination therapies with lamivudine\/tenofovir disoproxil fumarate for medication of treatment-na\u00efve HIV-1-positive adults: week 48 results of a randomized controlled phase 3 clinical trial followed by an open-label setting until week 96","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Western Pacific","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanwpc.2023.100769","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100769"}}